HJ
Heng Jiang
Credentials:
History
- 2024–2027
- 2020–2024
Medical School
Research
Using bispecific antibodies in a patient with peritoneal dialysis for relapsed multiple myeloma
Case report · Journal of Oncology Pharmacy Practice · 2025 · First of 3 authors · 5 citations
Letter or commentary · Journal of Hematology & Oncology · 2026 · 1 citations
Emerging agents and regimens for myeloproliferative neoplasms: updates from ASH 2025 Annual Meeting
Letter or commentary · Experimental Hematology and Oncology · 2026
- DL
3 papers
- YA
2 papers · 2 as a fellow
- AS
1 paper
- PS
1 paper · 1 as a fellow